- Paul E. SchubertCEO
Mr. Schubert is a seasoned medical industry veteran with over 36 years experience in healthcare devices and owner of a highly successful DME and clinical services company, Medical Treatment Systems. Through Mr. Schubert's efforts one of the most successful devices in health care device history was launched from a highly regarded teaching hospital in North Carolina. His DME company presently provides negative pressure therapy for over 20,000 patients annually.
He holds a degree in accounting from the University of Florida.
- Terry N. WilliamsCTO
Mr. Williams is a medical device executive with extensive expertise in development, approval, and commercialization of medical devices. He was founder and CEO of a start-up medical device and software company, Trac Medical, that successfully designed, manufactured and received FDA approval on 3 clinical devices. His company also developed and received 5 US Patents with acute care product offerings to Kinetic Concepts (KCI), General Electric Medical Systems, Baxter Healthcare and Philips Medical Systems before acquisition by the Authentidate Corporation which resulted in a successful public stock offering.
He holds a BS degree from the School of Life Sciences at NC State University.
- Dr. George Adams
Dr. George Adams is an Interventional Cardiologist at Rex Hospital affiliated with the University of North Carolina at Chapel Hill. He completed his Internal Medicine Internship and Residency at the University of Texas Southwestern and his General Cardiology, Interventional Cardiology and Masters of Health Sciences at Duke University. He is currently a Clinical Associate Professor of Medicine at the University of North Carolina at Chapel Hill and is the Director of Cardiovascular and Peripheral Vascular Research at Rex Hospital. Dr. Adams is well published in the field of complex peripheral vascular interventions in critical limb ischemic patients, development of regional systems of care for STEMI, and nuclear cardiology techniques. He currently leads a robust clinical research program enrolling patients in approximately 20 peripheral, carotid and coronary trials and is involved with device development for the management of coronary and peripheral vascular disease.